Researchers have developed a new test to more easily diagnose medulloblastoma, the most common malignant childhood brain tumor. The test -- which can distinguish between extremely high-risk medulloblastoma cases that need radiation therapy from those that are lower-risk and do not need radiation -- could help pave the way for personalized treatment options for children suffering from the disease. It relies on an antibody-based technique called immunohistochemistry which is widely available in clinical laboratories around the world.
from Top Health News -- ScienceDaily https://ift.tt/3BCVA87
Subscribe to:
Post Comments (Atom)
-
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one ...
-
Three treaties between the US and Hong Kong were suspended, the latest move to pressure China. from Yahoo News - Latest News & Headl...
-
Researchers observed a rise in adult central nervous system (CNS) infections, primarily aseptic meningitis caused by the varicella zoster vi...
No comments:
Post a Comment